Ready to evaluate structures and transactions to assuage investor concerns: Sun Pharma

Ready to evaluate structures and transactions to assuage investor concerns: Sun Pharma "As of now, the company has not received any query from SEBI with regards to whistleblower complaint, Sun Pharma founder and MD Dilip Shanghvi said.

No comments:

Post a Comment